Bio-Techne Corporation announced Wilson Wolf Manufacturing has met the trailing 12-month earnings before interest, taxes, depreciation, and amortization (EBITDA) target...
1 March 2023
Bio-Techne Corporation announced Wilson Wolf Manufacturing has met the trailing 12-month earnings before interest, taxes, depreciation, and amortization (EBITDA) target...
9 February 2023
Medical Alley
Catch up with the editors from Medical Alley as they interview ScaleReady Global Commercial Director, Josh Ludwig for their regular...
14 December 2021
Bio-Techne announced it has entered into a purchase option agreement with Wilson Wolf Corporation, solidifying resources and support for ScaleReady...
3 November 2021
ScaleReady sources Bio-Techne cytokines because of their commitment to supplying the entire cell and gene therapy industry with GMP-grade, animal...
7 October 2021
Josh Ludgwig, Global Director of Commercial Operations at ScaleReady discusses what makes the company uniquely positioned to support manufacturing across...
1 October 2021
As a member of The Alliance for Regenerative Medicine (ARM), ScaleReady committed to progressing regenerative medicine and advanced therapy manufacturing...
25 May 2021
In this interview, Josh Ludwig, Global Director of Commercial Operations at ScaleReady, describes how a scalable, cost-effective and practical manufacturing...
